Influenza Challenge and the Challenge of Drug Development
J Infect Dis
.
2019 Jan 7;219(2):171-172.
doi: 10.1093/infdis/jiy413.
Author
John Treanor
1
Affiliation
1
Infectious Diseases Division, Department of Medicine, University of Rochester Medical Center, New York.
PMID:
30053040
DOI:
10.1093/infdis/jiy413
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antiviral Agents*
Drug Development
Endonucleases
Humans
Influenza, Human*
Serine Endopeptidases
Substances
Antiviral Agents
Endonucleases
Serine Endopeptidases
sfericase